Drug intelligence / Profile preview

Prolact CR

Development stage
Unknown
Lead developer
Prolacta Bioscience
Administration
Oral
01

Overview

Prolact CR is a human milk-based caloric fortifier developed by Prolacta Bioscience for use in the neonatal intensive care unit (NICU). It is derived from donor human milk and consists of pasteurized human milk cream (approximately 25% milk fat) and human milk ultrafiltration permeate. The product is designed to increase the caloric density of mother's own milk or donor breast milk without significantly increasing the volume, which is critical for the growth and weight gain of premature and very low birth weight infants (typically those weighing less than 1,500 grams). While classified as a medical food or nutritional product in the United States and Canada, it is approved as a prescription drug in Japan under the brand name PreemieFort Enteral Solution CF for infants with very low birth weight or congenital gastrointestinal and heart disorders.

Brand names
Prolact CRPreemieFort Enteral Solution CF
Other names
human milk caloric fortifierhuman milk cream

Beyond the preview

Go deeper on Prolact CR.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prolact CR.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call